New research suggests that patients who come off popular slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who stop conventional diet and exercise plans.
Published data in a leading medical journal points out that while overweight people can lose a large proportion of their body weight while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month after stopping.
"People purchasing such treatments should be aware of the risk of rapid weight regain when the treatment ends," warns researcher Dr. Susan Jebb.
Such speed of regain suggests a return to pre-treatment mass within about a year and a half.
Weighing Therapies
The study, which looked at dozens of trials involving thousands of participants, compared the results of GLP-1 agonists with older methods.
The team point out that people who shed pounds through dieting usually have a less rapid creep back—perhaps 0.1 kg a month—after stopping.
Understanding the Fast Rebound
Experts propose the mode of action of the drugs explains the accelerated weight return.
The injections imitate a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Sustained high doses of GLP-1 levels far above than normal might result in the body to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' leads to hunger is no longer kept in check, making overeating a significant risk."
An Ongoing Issue?
Medical guidelines recommend the jabs for individuals with weight-linked health risks, alongside recommended lifestyle changes.
A number of clinicians contend that, due to the significant potential of relapse, the therapy might need to be ongoing.
This view is supported by drug manufacturers, who say that the findings "underscore the chronic character of excess weight," akin to managing conditions like diabetes.
Patient Experiences
People who have stopped the jabs describe a intense resurgence of appetite.
"It was like a switch that goes on and I was suddenly starving," recalled an individual.
This difficulty is compounded if patients have not adopted sustainable dietary or behavioural changes during therapy.
Significant Use
Figures show that millions of adults in the UK have tried weight-loss jabs in the past year, with desire being substantial.
- Adoption is greater among women compared to men.
- The middle-aged age group shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
Finally, researchers emphasize that while the jabs are effective tools for shedding pounds, they are not a permanent solution and maintained weight loss relies on combined lifestyle support.